Precigen Inc (PGEN)

Sep 26, 2026

Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? - Yahoo Finance

Sep 26, 2026

Sep 25, 2026

MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - TradingView

Sep 25, 2026

Sep 25, 2026

Precigen (PGEN) Secures FDA Platform Status For AdenoVerse And Future Therapies - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

B. Riley Securities initiates coverage of Precigen with Buy rating, $12 price target - TradingView

Sep 25, 2026

Sep 25, 2026

Precigen stock hits 52-week high at 8.05 USD - Investing.com

Sep 25, 2026

Sep 25, 2026

$Precigen (PGEN.US)$ ready for the next leg higher - Moomoo

Sep 25, 2026

Sep 25, 2026

PGEN Initiates Coverage On B. Riley Securities -- Rating Set to Buy - GuruFocus

Sep 25, 2026

Sep 25, 2026

B.Riley initiates Precigen stock coverage with buy on drug launch By Investing.com - Investing.com South Africa

Sep 25, 2026

Sep 25, 2026

Precigen Initiated at Buy by B. Riley Securities - Moomoo

Sep 25, 2026

Sep 25, 2026

Form 4 Precigen Inc For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026

Sep 25, 2026

B.Riley initiates Precigen stock coverage with buy on drug launch - Investing.com Canada

Sep 25, 2026

Sep 25, 2026

Form 4 Precigen Inc For: 25 September - Investing.com India

Sep 25, 2026

Sep 24, 2026

Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos? - Yahoo Finance UK

Sep 24, 2026

Sep 23, 2026

Vertex Posts Positive Phase II Data on Kidney Disease Drug - Zacks Investment Research

Sep 23, 2026

Sep 21, 2026

Precigen's AdenoVerse Receives FDA Platform Technology Designation - marketscreener.com

Sep 21, 2026

Sep 21, 2026

PGEN Looks 47.9% Undervalued on GF Value™ Despite Financial Chal - GuruFocus

Sep 21, 2026

Sep 21, 2026

FDA grants platform technology status to Precigen’s AdenoVerse - Investing.com

Sep 21, 2026

Sep 21, 2026

September 2026's Leading Growth Companies With Insider Backing - simplywall.st

Sep 21, 2026

Sep 21, 2026

Precigen Receives FDA Platform Technology Designation for AdenoVerse Platform - TradingView

Sep 21, 2026

Sep 18, 2026

Precigen (PGEN) Stock May Be Fully Valued On Its Current Sales Base - Yahoo Finance

Sep 18, 2026

Sep 18, 2026

Precigen, Inc. (PGEN) Stock Analysis: A 84% Upside Potential Sparks Investor Interest - DirectorsTalk Interviews

Sep 18, 2026

Sep 17, 2026

Precigen stock hits 52-week high at 7.74 USD By Investing.com - Investing.com Nigeria

Sep 17, 2026

Sep 17, 2026

Precigen stock hits 52-week high at 7.74 USD - Investing.com

Sep 17, 2026

Sep 14, 2026

Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock? - finance.yahoo.com

Sep 14, 2026

Sep 10, 2026

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

Sep 10, 2026

Sep 10, 2026

Can Papzimeos Drive Precigen's Growth Through the Rest of 2026? - Yahoo Finance

Sep 10, 2026

Aug 31, 2026

Precigen Insider Sold Shares Worth $1,376,400, According to a Recent SEC Filing - Yahoo Finance

Aug 31, 2026

Aug 30, 2026

Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock - simplywall.st

Aug 30, 2026

Aug 29, 2026

Precigen (PGEN) Director Jeffrey Kindler Sells 185,000 Shares - GuruFocus

Aug 29, 2026

Aug 29, 2026

Precigen director Jeffrey Kindler sells $1.38m in stock By Investing.com - Investing.com Australia

Aug 29, 2026

Aug 28, 2026

Precigen (PGEN) director sells 185K shares in one day - Stock Titan

Aug 28, 2026

Aug 28, 2026

Does Reliance On Papzimeos Skew Precigen’s (PGEN) Risk Profile Or Validate Its Focused Strategy? - Yahoo Finance

Aug 28, 2026

Aug 28, 2026

Is Precigen (PGEN) Undervalued After Reaching Quarterly Profitability? - sahmcapital.com

Aug 28, 2026

Aug 28, 2026

Precigen director Jeffrey Kindler sells $1.38m in stock - Investing.com

Aug 28, 2026

Aug 27, 2026

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Yahoo Finance

Aug 27, 2026

Aug 26, 2026

Precigen (PGEN) director plans 185,000-share 2026 sale - Stock Titan

Aug 26, 2026

Aug 25, 2026

Precigen COO Rutul Shah sells $375,000 in shares By Investing.com - Investing.com South Africa

Aug 25, 2026

Aug 25, 2026

Precigen CCO Phil Tennant sells $593,745 in stock By Investing.com - Investing.com Nigeria

Aug 25, 2026

Aug 25, 2026

Precigen Insider Sold Shares Worth $375,000, According to a Recent SEC Filing - marketscreener.com

Aug 25, 2026

Aug 25, 2026

Precigen (PGEN) insider lines up another stock sale after four recent trades - Stock Titan

Aug 25, 2026

Aug 25, 2026

Precigen (NASDAQ: PGEN) officer to sell 79,166 shares in 2026 - Stock Titan

Aug 25, 2026

Aug 25, 2026

Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers - Investing News Network

Aug 25, 2026

Aug 22, 2026

3 Growth Companies With High Insider Ownership And 55% Earnings Growth - Sahm

Aug 22, 2026

Aug 21, 2026

Precigen (PGEN) officer targets $259,935 insider stock sale - Stock Titan

Aug 21, 2026

Aug 21, 2026

Precigen (NASDAQ:PGEN) Trading Down 3.6%Here's Why - MarketBeat

Aug 21, 2026

Aug 21, 2026

$Precigen (PGEN.US)$ keep it up! - Moomoo

Aug 21, 2026

Aug 20, 2026

Precigen (NASDAQ:PGEN) Hits New 12-Month HighTime to Buy? - MarketBeat

Aug 20, 2026

Aug 20, 2026

Precigen stock hits 52-week high at 7.33 USD By Investing.com - Investing.com Australia

Aug 20, 2026

Aug 20, 2026

Reasons Why Investors Should Consider Betting on PGEN Stock - TradingView

Aug 20, 2026

Aug 19, 2026

Precigen (PGEN) Stock: Ends Up by 6.30% at $7.17 in the Latest Session; Key Range: Support at $6.81 and Resistance at $7.53 Frame the Range under the Current SnapshotPut Spread Alert - vinanet.vn

Aug 19, 2026

Aug 19, 2026

Stock Traders Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat

Aug 19, 2026

Aug 19, 2026

Alpine Woods Capital Investors LLC Takes $1.31 Million Position in Precigen, Inc. $PGEN - MarketBeat

Aug 19, 2026